1h Free Analyst Time
The publisher has been monitoring the montelukast sodium market and it is poised to grow by $ 1.88 billion during 2022-2026, accelerating at a CAGR of 6.1% during the forecast period. The report on the montelukast sodium market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for asthma medications, an increase in patient awareness, and a strong pipeline and new drug approvals.
The montelukast sodium market analysis includes type segment and geographic landscape.
The analyst's montelukast sodium market is segmented as below:
By Type:
- Tablets
- Chewable tablets
- Oral solutions
By Geographical Landscape:
- North America
- Europe
- APAC
- Rest of World (ROW)
This study identifies the patient assistance initiatives by governments and advocacy groups as one of the prime reasons driving the montelukast sodium market growth during the next few years. Also, an increase in collaborations and expanding research in curative approaches will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on the montelukast sodium market covers the following areas:
- Montelukast sodium market sizing
- Montelukast sodium market forecast
- Montelukast sodium market industry analysis
The analyst's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading montelukast sodium market vendors that include Apotex Inc., Aurobindo Pharma Ltd., Bio-Techne Corp., Cayman Chemical Co., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Hetero Healthcare Ltd., Hikma Pharmaceuticals Plc, Jubilant Pharmova Ltd., Krosyl Pharmaceuticals Pvt. Ltd., Merck and Co. Inc., Morepen Laboratories Ltd., Novartis AG, Simson Pharma Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Unichem Laboratories Ltd., Unimark Remedies Ltd., and Viatris Inc. Also, the montelukast sodium market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global montelukast sodium market: Apotex Inc., Aurobindo Pharma Ltd., Bio-Techne Corp., Cayman Chemical Co., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Hetero Healthcare Ltd., Hikma Pharmaceuticals Plc, Jubilant Pharmova Ltd., Krosyl Pharmaceuticals Pvt. Ltd., Merck and Co. Inc., Morepen Laboratories Ltd., Novartis AG, Simson Pharma Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Unichem Laboratories Ltd., Unimark Remedies Ltd., and Viatris Inc.Commenting on the report, an analyst said: "The latest trend gaining momentum in the market is patient assistance initiatives by governments and advocacy groups."
According to the report , one of the major drivers of this market is the increasing demand for asthma medications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Bio Techne Corp.
- Cayman Chemical Co.
- Cipla Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hetero Healthcare Ltd.
- Hikma Pharmaceuticals Plc
- Jubilant Pharmova Ltd.
- Krosyl Pharmaceuticals Pvt. Ltd.
- Merck
